Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7733470

Concept 2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-09-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,422,985,000 JPY
-3,008,665,000 JPY
-1,502,689,000 JPY
Profit (loss) attributable to owners of parent
-1,367,154,000 JPY
-3,002,063,000 JPY
-1,497,245,000 JPY
Comprehensive income
-1,371,235,000 JPY
-3,001,558,000 JPY
-1,496,322,000 JPY
Net assets
8,830,066,000 JPY
10,104,297,000 JPY
11,613,813,000 JPY
Total assets
9,206,417,000 JPY
10,592,771,000 JPY
12,098,817,000 JPY
Basic earnings (loss) per share
-5.43
-9.30
-20.42
-4.98
-10.18
Diluted earnings per share
Equity-to-asset ratio
0.905 xbrli:pure
0.916 xbrli:pure
0.926 xbrli:pure
Net cash provided by (used in) operating activities
-1,498,268,000 JPY
-2,988,040,000 JPY
-1,647,881,000 JPY
Net cash provided by (used in) investing activities
-37,941,000 JPY
-11,958,000 JPY
-9,608,000 JPY
Net cash provided by (used in) financing activities
150,640,000 JPY
2,330,000 JPY
2,330,000 JPY
Cash and cash equivalents
8,686,276,000 JPY
10,072,962,000 JPY
11,415,872,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.